1)Yaegashi Y, Shirakawa K, Sato N, et al : Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother 11:234-238,2005
2)遠藤重厚,八重樫泰法,佐藤信博,他:新しい敗血症の診断マーカーである可溶性CD14サブタイプの有用性について.エンドトキシン血症救命治療研会誌 9:46-50,2005
3)Kurihara T, Yanagida A, Yokoi H, et al : Evaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer, PATHFAST. Anal Biochem 375:144-146,2008
4)Okamura Y, Yokoi H : Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta 412:2157-2161,2011
5)Shozushima T, Takahashi G, Matsumoto N, et al : Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother 17:764-769,2011
6)Endo S, Suzuki Y, Takahashi G, et al : Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother 18:891-897,2012
7)石部頼子,小豆嶋立頼,高橋学,他:可溶性CD14サブタイプ(プレセプシン)は敗血症の重症度を良く反映する:1症例からの検討.日救命医療会誌 26:29-33,2012
8)小豆嶋立頼,高橋学,小鹿雅博,他:可溶性CD14サブタイプは敗血症の重症度を良く反映する:症例報告.岩手医誌 62:405-410,2010
9)Takahashi G, Suzuki Y, Kojika M, et al : Evaluation of responses to IVIG therapy in patients with severe sepsis and septic shock by soluble CD14 subtype monitoring. Med Postgrad 48:19-24,2010